A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Astellas Pharma Inc
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
M.D. Anderson Cancer Center
Genentech, Inc.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Eli Lilly and Company
Eli Lilly and Company
AbbVie
AstraZeneca
Eli Lilly and Company